Jefferies Upgrades Nektar Therapeutics (NKTR) to Hold; 'EZPEG back in the pipeline'
Tweet Send to a Friend
(Updated - May 10, 2023 9:27 AM EDT)
Jefferies analyst Roger Song upgraded Nektar Therapeutics (NASDAQ: NKTR) from Underperform ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Jefferies analyst Roger Song upgraded Nektar Therapeutics (NASDAQ: NKTR) from Underperform ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
